Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Unchanged |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RA CAPITAL MANAGEMENT L.P. | 2,805,045 5.400% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:10 pm Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 2,954,392 5.700% |
-940,000 (-24.14%) |
Filing History |
| 2022-02-14 06:12 am Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,864,800 5.600% |
-299,601 (-9.47%) |
Filing History |
| 2022-02-11 5:04 pm Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 7,326,117 14.200% |
-814,013 (-10.00%) |
Filing History |
| 2022-02-04 09:17 am Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Wellington Management Group LLP | 1,763,053 3.420% |
-1,141,669 (-39.30%) |
Filing History |
| 2022-01-20 4:27 pm Purchase |
2022-01-18 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,816,950 5.470% |
2,816,950 (New Position) |
Filing History |
| 2021-08-16 2:37 pm Purchase |
2021-08-05 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 3,894,392 7.600% |
3,894,392 (New Position) |
Filing History |
| 2021-02-16 5:28 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 8,140,130 17.900% |
8,140,130 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RA CAPITAL MANAGEMENT L.P. | 2,805,045 6.200% |
2,805,045 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 3,164,401 7.000% |
218,450 (+7.42%) |
Filing History |
| 2021-02-16 06:38 am Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
ForDyne B.V. | 6,131,079 13.490% |
6,131,079 (New Position) |
Filing History |
| 2021-02-12 4:24 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
MPM BIOVENTURES 2018 L.P. | 4,951,303 10.900% |
4,951,303 (New Position) |
Filing History |
| 2021-02-03 3:11 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Wellington Management Group LLP | 2,904,722 6.390% |
2,904,722 (New Position) |
Filing History |
| 2020-10-01 4:41 pm Purchase |
2020-09-21 | 13D | Dyne Therapeutics, Inc. DYN |
Vida Ventures II, LLC | 2,960,046 6.500% |
2,960,046 (New Position) |
Filing History |
| 2020-09-28 4:03 pm Purchase |
2020-09-17 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,945,951 6.500% |
2,945,951 (New Position) |
Filing History |